Tower Research Capital (TRC)’s Eloxx Pharmaceuticals ELOX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELOX
SL
Tower Research Capital (TRC)'s ELOX Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in Eloxx Pharmaceuticals (ELOX) in Q3 2026: 507 shares worth $7.76K. The stake represents ﹤0.01% of the portfolio and ranks #4444 among its holdings.
20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.
- Tower Research Capital (TRC) held 507 shares of Eloxx Pharmaceuticals worth $7.76K as of Q3 2026.
- Eloxx Pharmaceuticals was a new Tower Research Capital (TRC) position in Q3 2026.
- Eloxx Pharmaceuticals made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4444 holding.
- 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.